-
Characteristics of Parthenogenetic Stem Cells and Their Potential Treatment Strategy for Central Nervous System Diseases
03 Feb 2025 05:03 GMT
… results with traditional drug treatment and rehabilitation therapy … cells activated by interferon-γ promote recovery … rehabilitative and pharmaceutical procedures and biotechnological and bioengineered … undergoing clinical trials for regenerative medicine: case …
-
Dazukibart shows promise as treatment for dermatomyositis
28 Jan 2025 00:46 GMT
… , a type I interferon inhibitor, reduced dermatomyositis disease … Medicine, and colleagues wrote. “Studies have shown that type I interferon … ;beta receptor, positioning it as a potentially effective treatment … -controlled, phase 2 trial composed of 75 adults …
-
Tuberculosis Clinical Trial Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working In The Therapeutics Segment Delveinsight
23 Jan 2025 00:53 GMT
… (TST) or interferon-gamma release assay … about tuberculosis treatment drugs @ Drugs for Tuberculosis Treatment
A … @ Tuberculosis Clinical Trials
Tuberculosis Therapeutics Assessment … Pharmaceuticals, Tianjin CanSino Biotechnology, Global Alliance for TB Drug …
-
Research Progress of NK Cells in Glioblastoma Treatment
17 Jan 2025 13:59 GMT
… various cytokines, such as interferon IFN-γ, TNF-α, interleukin … undergoing clinical trials for GBM treatment (CAR2BRAIN; NCT0338978 … continuous progress of biotechnology, we firmly believe … Doctor Foundation of the Second Affiliated Hospital of Xi’an Medical …
-
Herbal Medicines as Complementary Therapy for Managing Complications in COVID-19 Patients with Diabetes Mellitus
15 Jan 2025 20:05 GMT
… complementary treatments, including herbal medicines. Some herbal medicines were … using convalescent plasma and interferon (IFN), together … identification of possible drug treatment of coronavirus disease- … expressed inPichia pastoris. Biotechnol Lett. 2012;34 …
-
Novel Insight into the Modulatory Effect of Traditional Chinese Medicine on Cerebral Ischemia-Reperfusion Injury by Targeting Gut Microbiota: A Review
10 Jan 2025 10:33 GMT
… ,97 the type I interferon pathway,98 and the … -controlled trial found that Naoxintong capsule was a safe drug for … effect of traditional Chinese medicine in the treatment of cerebral ischemia- … . doi:10.3390/pharmaceutics15122746
142. Xuejiang W, Magara …
-
PPARγ mediated enhanced lipid biogenesis fuels Mycobacterium tuberculosis growth in a drug-tolerant hepatocyte environment
06 Jan 2025 21:47 GMT
… bacteria like type 1 interferon signalling pathway, regulation of … phenomenon of Mtb surviving drug treatment for longer durations in … the Postgraduate Institute of Medical Education and Research, Chandigarh … ABI 7500 FAST instrument. Beta-actin was used as …
-
Immune Checkpoint Inhibitor Combined with Antiangiogenic Agent Synergistically Improving the Treatment Efficacy for Solid Tumors
31 Dec 2024 10:17 GMT
… , CheckMate9ER and CLEAR trials, demonstrated superior efficacy … line treatments. In the CORRECT trial, the third-line drug … antitumor and antiangiogenic therapy. Pharmaceuticals. 2010;3(3): … of tumor angiogenesis by interferon-gamma by suppression of …
-
Short and Medium Chain Fatty Acids in a Cohort of Naïve Multiple Sclerosis Patients: Pre- and Post-Interferon Beta Treatment Assessment
15 Nov 2024 09:02 GMT
… , Center for Advanced Medical and Pharmaceutical Research, George Emil … Responders. CNS Neurol Disord Drug Targets. 2018;17(6 … double-blind, placebo-controlled trial. UBC MS/MRI … et al. Response to interferon-beta treatment in multiple sclerosis patients: …
-
Synairgen backer ready to pump £18-£19 million into phase II trial
20 Dec 2024 10:46 GMT
… of SNG001, its investigational inhaled interferon beta treatment.
The funding includes a … to supporting trial costs, the investment will cover drug manufacturing and … candidate for future partnerships with pharmaceutical companies.
CEO Richard Marsden …
About
© 1995-2025